Efficacy Optimizing Research of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy

NCT01341743 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

360

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis B

Interventions

DRUG: Entecavir
DRUG: Entecavir, Adefovir
DRUG: Entecavir, Adefovir

Sponsor

Nanfang Hospital, Southern Medical University

Collaborators

[object Object]